Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

News in brief

SCRS makes Covance its fifth CRO partner

26-Jun-2015 - The Society for Clinical Research Sites (SCRS), a trade organization representing the interests of clinical research sites, has announced a two-year partnership with LabCorp’s Covance. 

News in brief

Huntingdon Life Sciences unveils new name post-Harlan integration

25-Jun-2015 - Preclinical CRO Huntingdon Life Sciences has announced a new name, which it changed to mark the integration of Harlan Laboratories.

Sweden’s Recipharm looks to engage customers earlier with $1.8m acquisition

23-Jun-2015 - Recipharm has completed the acquisition of Uppsala, Sweden-based CRO OnTarget Chemistry for about $1.8m (SEK 15.1m). 

Scientists create 3D multiple myeloma model to aid preclinical development efforts

22-Jun-2015 - Scientists have developed a new way of visualizing multiple myelomas in 3D by replicating tumours in hens’ eggs in a approach they say will aid drugmakers.

Glowing mice with working immune systems make for better cancer models say scientists

19-Jun-2015 - Mice engineered to recognise light-emitting markers as self will let cancer drug developers to track tumor growth in animals with functioning immune systems say US researchers.

Medivir had no concerns about selecting GVK for discovery services; Assessing cathepsin S options

18-Jun-2015 - Swedish drugmaker Medivir has consolidated its drug discovery efforts though a deal with Indian CRO GVK Bio.

Mammary glands in a dish: Scientists recreate tissues for better models; spin out CRO planned

15-Jun-2015 - Researchers say a hydrogel that prompts cells to form tissue-like structures in vitro could be used to make more accurate preclinical disease models.

US spends billions on irreproducible preclinical studies say researchers

12-Jun-2015 - The US spends billions on preclinical research that cannot be replicated due to errors in design, problems with lab protocols and mistakes during data analysis according to new research.

FDA offers guidance for running early-phase trials for gene, cell therapies

12-Jun-2015 - As the hype continues to hover around the promise of gene and cell therapies, the latest guidance from the FDA will help sponsors, CROs and investigators design early-phase clinical trials...

Organovo on track for 3D bio-printed kidney tissue model

11-Jun-2015 - Organovo is looking to bring its 3D bioprinted kidney tissues to market in September 2016 following the launch of its preclinical Human Liver system.

Charles River raises questions about its own supply chain

11-Jun-2015 - Minerals used to manufacture two of Charles River Laboratories’ products may be derived from questionable sources in Africa, though following a review of suppliers, the company has yet to fully...

Unchained Labs ups its biologics stability toolset with Avia acquisition

08-Jun-2015 - Unchained Labs has acquired Avia Biosystems and its characterization tool, the Isothermal Chemical Denaturation (ICD) system, to support the growing demand for biologics stability testing.

Animal research ban not possible says EC after rejecting petition

04-Jun-2015 - Replacing animal studies in drug development is impossible according to the European Commission, which has rejected a petition calling for a ban signed by 1.2m people. 

Profil Institute lands new alliance focused on metabolic disease

04-Jun-2015 - CRO Profil Institute for Clinical Research will collaborate with Denmark-based Gubra ApS, a metabolic preclinical and drug discovery company, to discover and translate into clinical research novel drug targets, compounds...

Charles River seeing more strategic relationships, CEO says

03-Jun-2015 - As Big Pharma and biotech companies continue to outsource more of their work, one of the leaders in the preclinical and discovery space – Charles River Laboratories – is seeing...

AMRI partners with biotech to aid drug discovery efforts at new Buffalo site

02-Jun-2015 - Albany Molecular Research Inc. (AMRI) has signed a three-year collaborative agreement with biotechnology company HarkerBIO to co-market their drug discovery services to clients. 

Pediatric trials in EU increase as overall trials decline, Commission report says

01-Jun-2015 - The proportion of pediatric trials of all clinical trials in the EU continues to increase since the integration of a Pediatric regulation in 2007, despite a decrease in the number...

Dispatches from EATRIS Translational Research Conference, Amsterdam

EATRIS: Pharma has a vital role in translational medicine

29-May-2015 - When translational medicine researchers recognise the need for pharma industry cash but are wary of handing over drug development to for-profit organisations, how can public-private collaborations bridge the culture gap?

LabCorp outlines near-term goals following Covance integration

27-May-2015 - With the integration of Covance moving along steadily, Dave King, chairman and CEO of LabCorp, told investors last week at the UBS Healthcare Conference that LabCorp is ramping up a...

Strike while the ion is hot: Metrion targets demand for cardiac risk testing

19-May-2015 - Making sure candidate drugs are free of cardiac risks means drug industry demand for ion channel screening expertise is growing according to new CRO, Metrion.

Xention aims to cash in ion channel knowhow through new CRO

18-May-2015 - Heart drug developer Xention has launched a contract screening business designed for drug industry customers seeking ion channel services.

Charles River looks to save $35m from new efficiency initiatives

07-May-2015 - As competition and pricing get fiercer for CRO Charles River Laboratories, the company is looking to save about $35m from new efficiencies in its RMS (Research Models and Services) business,...

News in brief

QPS adds new in vitro dermatology and transdermal research lab in North Dakota

06-May-2015 - Full-service CRO QPS Holdings has opened its new in vitro dermatology and transdermal research laboratory in Fargo, North Dakota. 

Scientists target Hep C virus using CRISPR-Cas technology

05-May-2015 - Scientists in the US have used the CRISPR-Cas system to target the RNA of hepatitis C virus (HCV).

Roundup of CRO partnerships, offerings and other news

04-May-2015 - A number of small, mid-sized and large CROs (contract research organizations) and other companies tied to the world of clinical research have announced various partnerships and other financial moves over...

Key Industry Events


Access all events listing

Our events, Shows & Conferences...

On demand Supplier Webinars

The in-PharmaTechnologist Anti-counterfeiting Forum
William Reed Business Media
All supplier webinars